RMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatment

Hemanth Kumar, A. K. and Narendran, G. and Kumar, R. S. and Ramachandran, G. and Sekar, L. and Raja, K. and Swaminathan, S. (2015) RMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatment. The International Journal of Tuberculosis and Lung Disease, 19 (7). pp. 805-807. ISSN 10273719

Archive 201538.pdf - Published Version Download (65kB)

Affiliation:	ICMR-National Institute for Research in Tuberculosis
Item Type:	Article
Uncontrolled Keywords:	human immunodeficiency virus; tuberculosis; anti-tuberculosis treatment; pharmacokinetics; rifampicin
Subjects:	Tuberculosis > Laboratory Research > Biochemical Tuberculosis > Clinical Research
Divisions:	Basic Science Research > Biochemistry Clinical Research
Depositing User:	Dr. Rathinasabapati R
Date Deposited:	28 Sep 2022 11:22
Last Modified:	28 Sep 2022 11:23
URI:	http://eprints.nirt.res.in/id/eprint/1384

Actions (login required)

View Item